Angiotech narrows losses following bankruptcy, restructuring

November 16, 2012 by MassDevice staff

Angiotech Pharmaceuticals cuts losses in half during its 3rd quarter after the company undertook restructuring measures after filing for bankruptcy last year.

Angiotech logo

Angiotech Pharmaceuticals unveiled its 3rd quarter results, demonstrating narrowed losses in the year following the company's bankruptcy and restructuring efforts.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.